Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-04449913 Phase 2 Cancer Study in Japan
jRCT2080222674Phase 2Completed
- Start
- Dec 2014
- Modality
- Small Molecules
01
Overview
Phase 2 trial of glasdegib in cancer. Started Dec 2014; status: completed.
02
Drugs
glasdegib
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080222674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222674.